Full Text (PDF)
Review Article

Contribution of Dr. Mayanard M. Mirin in Pediatrics Science and Child Development

Dipali Kanbarao More, Kasumbiwal Ajay H, Mangesh Vijayrao Dhake, Pranita Tambe

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Pediatric Education and Research 13(2 (Special Supplement -I)):p 189-191, July-December 2025. | DOI: 10.21088/per.2321.1644.13225.34

How Cite This Article:

Kasumbiwal Ajay H., Dake Mangesh V., Birajdar Shailaja B., et al. Contribution of Dr. Mayanard M. Mirin in Pediatrics Science and Child Development. Pediatr. Edu. Res. 2025; 13(2): 189-191.

Timeline

Received : December 15, 2025         Accepted : December 28, 2025          Published : December 30, 2025

Abstract

Dr. Maynard M. Mirin was an influential mid-20th-century microbiologist whose foundational work significantly advanced the understanding of bacterial physiology, virulence, and early vaccine development. His research focused on encapsulated pathogens such as Haemophilus influenzae and Streptococcus pneumoniae, contributing to early knowledge of polysaccharide antigens and antimicrobial susceptibility. Working during a period with limited laboratory technology, Dr. Mirin encountered major challenges, including difficulties in purifying bacterial polysaccharides and insufficient understanding of host-pathogen interactions. Despite these obstacles, he achieved notable breakthroughs, including improved antigen extraction techniques, standardization of microbiological culture methods, and insights into bacterial capsule function that later informed the development of modern conjugate vaccines. His contributions provided crucial scientific groundwork for later researchers who pioneered vaccines that dramatically reduced global childhood morbidity and mortality. Dr. Mirin’s career reflects the importance of incremental scientific progress and meticulous research in shaping major public health advancements. Though not widely recognized outside academic circles, his work remains essential to microbiology, pediatric infectious disease prevention, and vaccine research. His legacy underscores how foundational discoveries continue to influence and strengthen contemporary medical science. Key Messages: Dr. Maynard M. Mirin’s pioneering research on bacterial physiology, polysaccharide antigens, and early vaccine development laid crucial scientific foundations that enabled later breakthroughs in conjugate vaccine technology. His meticulous work, despite limited technology of his era, continues to influence modern microbiology and has indirectly contributed to major improvements in global child health.


References

  • 1.   Mirin M.M. Studies on the capsular polysaccharides of Haemophilus influenzae. J Bacterial. 1954; 68(3): 215-22.
  • 2.   Mirin M.M., Jacobs E. Techniques for purification of bacterial antigens. J lmmunol. 1956; 77(1): 45-53.
  • 3.   Mirin M.M. Antibiotic susceptibility patterns of respiratory pathogens. Am J Med Sci. 1958; 236(4): 321-7.
  • 4.   Robbins J.B., Schneerson R. The development of polysaccharide vaccines: Historical foundations. Rev Infect Dis. 1984; 6 (Suppl 2): S282-90.
  • 5.   Anderson P. Bacterial polysaccharides and immunity. Pediatr Res. 1978; 12(2): 111-7.
  • 6.   Smith D.H., Ingram D.L. Advances in encapsulated bacterial vaccines. Clin Microbial Rev. 1989; 2(1): 1-19.
  • 7.   Peltola H. Worldwide impact of Haemophilus influenzae type b vaccination. Clin Microbial Rev. 2000; 13(2): 302-17

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

"The authors report no conflicts of interest in this work."


About this article


Cite this article

Kasumbiwal Ajay H., Dake Mangesh V., Birajdar Shailaja B., et al. Contribution of Dr. Mayanard M. Mirin in Pediatrics Science and Child Development. Pediatr. Edu. Res. 2025; 13(2): 189-191.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
December 15, 2025 December 28, 2025 December 30, 2025

DOI: 10.21088/per.2321.1644.13225.34

Keywords

Dr. Maynard M. MirinMicrobiologyBacterial polysaccharidesVaccine developmenEncapsulated bacteriaHaemophilus influenzaeStreptococcus pneumoniaeAntimicrobial resistanceImmunologyConjugate vaccinesScientific breakthroughsInfectious disease research

Article Level Metrics

Last Updated

Monday 07 September 2026, 04:44:41 (IST)


1862

Accesses

4
192
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received December 15, 2025
Accepted December 28, 2025
Published December 30, 2025

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share